In its classical genomic mode of action, the aryl hydrocarbon receptor (AhR) acts as a ligand activated transcription factor regulating expression of target genes such as CYP1A1 and CYP1B1. Some ligands may also trigger more rapid nongenomic responses through AhR, including calcium signaling (Ca 2+ -release from intracellular stores followed by a later phase of extracellular Ca 2+ -influx, consistent with store operated calcium entry (SOCE). These effects was accompanied by an AhR-dependent reduction in ordered membrane lipid domains, as determined by di-4-ANEPPDHQ staining. Addition of cholesterol inhibited both the pyrene-induced [Ca 2+ ] i -increase and alterations in membrane lipid order. In conclusion, we propose that pyrene binds to AhR, act as an antagonist of the canonical genomic AhR/Arnt/CYP1-pathway, reduces ordered membrane lipid domains, and activates AhR nongenomic Ca 2+ -signaling from intracellular stores.
In its classical genomic mode of action, the aryl hydrocarbon receptor (AhR) acts as a ligand activated transcription factor regulating expression of target genes such as CYP1A1 and CYP1B1. Some ligands may also trigger more rapid nongenomic responses through AhR, including calcium signaling (Ca 2+ ). In the present study we observed that pyrene induced a relatively rapid increase in intracellular -free medium indicated that the pyrene-induced AhR nongenomic [Ca 2+ ] i increase was initiated by Ca 2+ -release from intracellular stores followed by a later phase of extracellular Ca 2+ -influx, consistent with store operated calcium entry (SOCE). These effects was accompanied by an AhR-dependent reduction in ordered membrane lipid domains, as determined by di-4-ANEPPDHQ staining. Addition of cholesterol inhibited both the pyrene-induced [Ca 2+ ] i -increase and alterations in membrane lipid order. In conclusion, we propose that pyrene binds to AhR, act as an antagonist of the canonical genomic AhR/Arnt/CYP1-pathway, reduces ordered membrane lipid domains, and activates AhR nongenomic Ca 2+ -signaling from intracellular stores.
Introduction
The aryl hydrocarbon receptor (AhR), which is a basic helix-loophelix PAS transcription factor, plays a central role in regulating toxicity from PAHs. In its classical mode of action, ligand-activated AhR translocates to the nucleus and dimerizes with the AhR nuclear translocator (Arnt). The AhR-Arnt complex then binds to so-called dioxin or xenobiotic response elements (DREs or XREs) in the promotor region of target genes. The prototypical genes activated by AhR are the cytochrome P450 enzymes CYP1A1 and CYP1B1, but AhR also regulates a number of other genes including many central proinflammatory mediators [1, 2] . Notably, AhR-signaling is highly ligand specific and not restricted to the classical mode of action [3, 4] . Nonclassical AhRsignaling involves crosstalk with a number of other transcription factors and signaling molecules independently of Arnt activation [2] [3] [4] . In addition, it has been suggested that many of the toxic effects of the AhR ligand 2,3,7,8-tetrachlorodibenzodioxin (TCDD) could be due to nongenomic AhR-signaling where the receptor rather functions as a signaling molecule in the cytosol [1] . As such, the emerging pattern of AhR signaling is strikingly similar to the signaling from a number of nuclear receptors, including estrogen receptor (ER), which also involves both genomic and nongenomic modes of action [5] .
As for ER-signaling, AhR nongenomic responses appear to involve both activation of protein kinases as well as mediation of calcium (Ca 2+ ) responses within min after exposure, hence preceding the genomic activation of target genes [1, 3, 5] . These early cytosolic responses of the AhR are far less understood than the genomic mode of action and have predominately been investigated for TCDD. It is therefore unclear whether genomic and nongenomic signaling is triggered simultaneously through interaction with the same motifs within the AhR-PAS-B binding pocket, or whether the rank order of ligand potencies could differ for induction of genomic and nongenomic signaling. Polycyclic aromatic hydrocarbons (PAHs) constitute a central group of AhR ligands originating from incomplete combustion of organic materials. The main toxicological concern has historically been carcinogenic effects, and CYP1A1/CYP1B1is central in the metabolic activation and subsequent mutagenic effects of several PAHs [6] . In risk assessment the toxicity of PAHs has been converted into toxicity equivalency factors (TEFs) based on estimates of relative carcinogenicity compared to the known human carcinogen benzo[a]pyrene (B[a]P) [7] . Pyrene is among the most abundant PAHs in outdoor air occurring at concentrations that are orders of magnitudes higher than B[a]P [8] , but is not classifiable as carcinogen to humans (IARC group 3 compound), and has a very low TEF value of 0.001 [7] . However, pyrene exposure has been associated with asthma in children [9] and cardiovascular disease [10] . Studies in zebrafish embryos suggest that pyrene may induce peripheral vascular defects, cardiotoxicity and neuronal cell death [11] [12] [13] . Moreover, pyrene and its derivatives, but not B[a]P or β-naphthoflavone, potentiate pro-inflammatory responses induced by a toll-like receptor-3 ligand [14] . This suggests that pyrene triggers some effects that are distinctly different from B[a]P.
The reported lack of effect on CYP1A1/CYP1B1expression in human cells suggest that pyrene may have limited ability to bind and activate AhR [15] [16] [17] . In contrast, it appears that pyrene induce CYP-expression in fish and rats, although with considerable lower potency than B[a]P [18] [19] [20] , and it has been suggested that developmental toxicity of pyrene in zebrafish is mediated through AhR-dependent mechanisms due to qualitative similarities with effects from TCDD [11] . Studies from our lab have shown that the nitro-derivative 1-nitropyrene is capable of inducing CYP1A1 expression in rat Hepa1c1c7 cells, but fails to do so in human bronchial epithelial BEAS-2B cells [21, 22] . This could be due to differences in ligand selectivity and gene regulation between the human AhR and AhR from other species [23] [24] [25] . One possibility is that pyrene and pyrene derivatives could bind the human AhR, but fail to induce the classical genomic signaling.
Previous studies from our consortium have shown that pyrene induces a relatively rapid increase in [ in parallel with alteration in membrane organization in HMEC-1 cells. This strongly supports the notion that pyrene may have unique toxicological effects, and shows that AhR nongenomic signaling may be triggered independently of the classical genomic pathway.
Materials and methods

Chemicals
Benzo 
Cell culture
Human endothelial HMEC-1 cells, obtained from ATCC through LGC Standards (Wesel, Germany) were routinely maintained in MCDB 131 medium containing epidermal growth factor (10 ng/mL), hydrocortisone (1 µg/mL), penicillin (50 unit/mL), and streptomycin (50 µg/ mL) and supplemented with 10% FBS, according to the providers' instructions. Experiments were performed on HMEC-1 cells at passage numbers 22-32. Human embryonic kidney HEK293 cells were maintained in Dulbecco's modified Eagle's medium containing penicillin (50 unit/mL), and streptomycin (50 µg/mL) and supplemented with 10% FBS. The HEK293 cells was a gift from the late Hervé Paris, INSERM, Toulouse, France. The passage number of and origin of these cells, that was used in a limited number of experiments are not known. HEK293 cells permanently expressing β1-/β2ADR were obtained by β1-/β2ADR cDNA transfection using Lipofectamine (Invitrogen) as described elsewhere [26] . Chemicals were commonly prepared as stock solution in dimethyl sulfoxide (DMSO). The final concentration of solvent did not exceed 0.2% (v/v); control cultures received similar concentration of DMSO.
Cells used for Ca 2+ measurements or fluorescence measurements of membrane order were grown on glass coverslips to 50-60% confluency and serum starved for a minimum of 12 h prior to exposure. The glass coverslips were sterilized in ethanol of increasing concentrations from 70 to 99%, and then coated with serum proteins using pure FBS prior to cell culture. Cells used for q-PCR were cultivated in 6-well plates, grown to near confluence and serum starved for a minimum of 12 h prior to exposure.
Calcium measurements
HMEC-1 were grown on glass lamellas to 50-60% confluency and serum starved for a minimum of 12 h prior to exposure. Before exposure cells were mounted in exposure chambers containing 1 mL cell suspension buffer. Calcium cell suspension buffer contained: 134.8 mM NaCl, 4.7 mM KCl, 1.2 mM K2HPO4, 1 mM MgCl2, 1 mM CaCl2, 10 mM glucose, 10 mM HEPES, pH 7.4. Cells were washed two times with the buffer before loading with Fura-2AM for 30 min. Inhibitors were added during this loading period, and after the loading buffer had been washed off. Calcium-free cell suspension buffer containing the extracellular calcium chelator ethylene glycol tetra acetic acid (EGTA) was used after loading in experiments on extracellular Ca 2+ dependency.
Variations in intracellular Ca 2+ concentrations [Ca 2+ ] i were analysed in HMEC-1 cells exposed to all four DEP-OE, by micro-spectrofluorometry using the Ca 2+ sensitive probe Fura-2AM, as previously reported [27] . Briefly, cells were incubated at 37°C in cell suspension buffer supplemented with 1.5 µM Fura-2AM and 0.006% pluronic acid. ] i using an imaging system equipped with a Retiga 1300I fast-cooled monochromatic digital camera (12-bit) (Qimaging, Burnaby, BC, Canada), and a monochromator for fluorophore excitation. Image acquisition and analysis, involving determination of pixels assigned to each cell, was performed with METAFLUOR software (Universal Imaging, Downingtown, PA, USA). Average pixel value for each cell, was obtained with excitation at both wavelengths and corrected for background. We obtained the ratio by dividing the 340-nm by the 380-nm fluorescence image on a pixel-by-pixel base (R = F340 nm/F380 nm. Results are presented as normalized calcium level compared to basal [Ca 2+ ] i measured 3 min prior to exposure. Area under the curve (AUC) was calculated from baseline (1.0).
Determination of structural perturbation of plasma membrane
Plasma membrane-order was visualized by confocal fluorescence microscopy using the membrane order sensitive di-4 ANEPPDHQ probe. This probe displays a fluorescent spectral blue-shift from 620 nm when incorporated into membranes with a low lipid order (in a liquid disordered phase, Ld) to 560 nm when inserted into membranes with a high lipid order (in a liquid-ordered phase, Lo). After acquisition using confocal fluorescence microscopy of both disordered and ordered-phase fluorescence images, a new image, indicative of membrane lipid order, was obtained by calculating the generalized polarization (GP) value, a ratiometric measurement of fluorescence intensities for each pixel which is correlated to membrane lipid order [28] . Briefly, after each treatment, HMEC-1 cells grown on glass coverslips were washed in phosphate buffer saline (PBS) and then fixed in 4% paraformaldehyde in PBS at 4°C. After three washes in PBS, the cells were stained with 5 μM di-4 ANEPPDHQ for 90 min and washed twice in PBS. Cells were then visualized with confocal fluorescence microscope LEICA DMI 6000 CS (Leica Microsystems, Wetzlar, Germany). Under excitation at 488 nm with an argon ion laser, ordered membrane images were acquired with a photomultiplier tube (PMT) range of 500 to 580 nm whereas for disordered membrane images, the PMT range was 620-750 nm (magnification × 400). Using Fiji imaging processing software (ImageJ; National Institutes of Health, Bethesda, USA) and the macro published by Owen et al. [28] , GP images were generated according to the following calculation: GP = (I 500-580 − I 620-750 )/ (I 500-580 + I 620-750 ). On each GP image generated (containing usually between 1 and 3 cells), a GP values was measured and normalized by subtraction of the mean of all GP values found for DMSO-treated cells (ΔGP values). Then, ΔGP values of images from at least 3 experiments were used to generate a dot blot. Finally, the global mean of ΔGP values for each condition was calculated from a minimum of 10 images.
Changes in bulk membrane fluidity were explored by electron paramagnetic resonance (EPR) spectroscopy using paramagnetic reporter groups incorporated into the membrane, as previously described [29] . Membranes were spin labelled by incubating cell suspensions at 37°C for 15 min with 12-doxyl stearic acid (50 μg/mL). The EPR spectra of labelled samples were acquired at an ambient temperature on a Bruker Elexsys EPR spectrometer operating at 3509 G center field, 20 mW microwave power, 9.86-GHz microwave frequency, 1.77 G modulation amplitude and 100 kHz modulation frequency. The fluidity of the labelled membranes was quantified by calculating the order parameter S, which is inversely related to membrane fluidity.
Immunocytochemical staining and fluorescence microscopy
Cell cultures were fixed with 4% paraformaldehyde in PBS for 10 min, washed in PBS for 10 min, briefly dipped in H2O, and dried. Fixed cells were incubated with rabbit anti-Ahr (Santa Cruz Biotechnology, Dallas, Texas, USA) diluted (1:100) in PBS with 1% BSA for 20 h, followed by 2 × 10 min washes in PBS, a brief dip in H 2 O, and dried. The cells were then exposed to Alexa488-conjugated donkey antirabbit IgG (1:200, Jackson Immunoresearch, West Grove, PA, USA) for one h, and washed 2 × 10 min in PBS, briefly dipped in H 2 O, dried, and mounted with Dako Fluorescent Mounting Medium (Dako Denmark A/ S, Glostrup, Denmark). Hoechst dye (H33254, 0.05 μg/ml was added to the last washing buffer. A Leica DMRE fluorescence microscope equipped with A and L5 fluorescence filter cubes were used for observations. An F-view CD camera and Analysis 3.1 software (Olympus, Tokyo, Japan) were used for documentation.
Gene silencing by RNA interference
HMEC-1 cells were transiently transfected with ON-TARGETplus SMARTpool siRNAs against AhR, or ON-TARGETplus non-targeting (NT) control siRNAs (Dharmacon, Chicago, IL; USA). Briefly described, semi-confluent cells were transfected with 100 nM siRNAs using Dharmafect-1 transfection reagent diluted in antibiotic-free culture medium, as previously described [16] . Forty-eight h after transfection, cells were exposed to pyrene and analysed for effects on Ca 2+ -signaling.
Gene expression analysis by real-time PCR
Total RNA was isolated using NucleoSpin RNA Plus (MachereyNagel; Düren, Germany) and reverse transcribed to cDNA on a PCR System 2400 (PerkinElmer, Waltham, MA, USA) using a High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). Real-time PCR was performed using pre-designed TaqMan Gene Expression Assays and TaqMan Universal PCR Master Mix and run on ABI 7500 fast (Applied Biosystems). Gene expression of CYP1A1 (Hs00153120_m1) and CYP1B1 (Hs02382916_s1) were normalized against GAPDH (Hs02758991_g1), and expressed as fold change compared to 
In silico molecular modelling and docking
The homology models of the human AhR-PAS-B in the agonist and antagonist conformation were built and refined as previously described by Bisson and colleagues [30] . Molecular Docking was run as reported elsewhere [30] . The ICM program relies on global optimization of the entire flexible ligand in the receptor field and combines large-scale random moves of several types with gradient local minimization and a search history mechanism. In the ICM-VLS (Molsoft ICM) screening procedure, the scoring function should give a good approximation of the binding free energy between a ligand and a receptor, and its usually a function of different energy terms based on a force-field [31] . The lower the ICM score, the higher the chance the ligand is a binder.
Statistical analysis
Statistical analyses were performed by ANOVA with Holm-Sidak post-test for multiple comparisons. Threshold for statistical significance was set at P > 0.05. The gene expression data were analyzed using the ΔCT-values from the q-PCR measurements. All calculations were based on analysis of independent experiments (biological replicates), with exception of the membrane-order measurements by confocal microscopy. Due the inherent variability in di-4-ANEPPDHQ-staining among individual cells, a very high counting-number is needed to obtain statistical significance. The statistical analyses of these data were therefore based on pooled technical replicates from three or more independent experiments. All calculations were performed with GraphPad Prism 6 software (GraphPad Software, Inc., San Diego, CA).
Results
Pyrene triggers a transient increase of intracellular calcium concentration in HMEC-1 cells
We first assessed the effects of pyrene on calcium signaling in human microvascular HMEC-1 cells. Briefly, cells were incubated with the calcium sensitive fluorescent probe Fura-2-AM, and alterations in calcium signaling were recorded by continuous microscopy imaging. Three min after recordings started, cells were exposed to 1 µM Pyrene. As seen in Fig. 1 
Pyrene induces [Ca
2+ ] i increase through AhR-dependent mechanisms
To investigate the potential role of AhR-dependent in regulation Ca 2+ -responses, HMEC-1 cells were pre-incubated with CH223191, a well-known AhR antagonist, prior to pyrene exposure. As shown in Fig. 2A , CH223191 treatment abrogated the Ca ] i in HEK293 cells that could also be abrogated by CH223191 treatment (Fig. 2C) . This suggest that AhR was essential for the pyrene-induced increase in [Ca 2+ ] i , and that this AhR-dependent response was not restricted to HMEC-1 cells.
Pyrene docks in the AhR antagonist conformation in silico
The possible interaction between pyrene and AhR was assessed by in silico molecular docking based on homology models. The AhR agonists TCDD and B[a]P, the AhR antagonists GNF-351 and CH223191, as well as pyrene were first docked into a model of the human AhR-PAS-B binding pocket in the agonist conformation. TCDD docked with the highest score, establishing a dual hydrogen bond interaction with the side chain of Ser 88/Ser 365 and His 14/His 291 (Fig. 3A, Table 1 ). B[a] P docked with a lower score of −6.8 (Fig. 3B, Table 1 ), which remains above the threshold value of −5.314, previously calculated with this model, for predicting AhR agonist activity [30] . Based on this threshold value, both antagonists and pyrene were not predicted being agonists of the human AhR ( Table 1) .
The AhR antagonists GNF-351 and CH223191, as well as pyrene, were then docked into the human AhR-PAS-B binding pocket in the antagonist conformation. GNF-351 docked with the highest score of ] i was measured and normalized as described in Section 2. Measurements were started three min before exposure.
* Statistically significant effect of the inhibitor.
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−35.14, establishing two hydrogen-bond interactions with the side chain of Gln106/Gln 383 and the backbone carbonyl of Gly 42/Gly 321 (Fig. 4A , Table 2 ). The antagonist CH223191 docked with a lower score of −25.73, and similarly to GNF-351, favouring a hydrogen bond interaction with the side chain of Gln106/Gln 383 (Fig. 4B , Table 2 ). Pyrene docked with the lowest score of −19.79 and without noncovalent bindings involved (Fig. 4C , Table 2 ). Interestingly, the score and the strength of interaction between the ligand and residue Gln 106/ Gln 383, highly correlate with the ranking of AhR binding, going from nanomolar (GNF-351), to low-(CH223191) and high-(pyrene) micromolar range. Moreover, as shown in Fig. 4A -B, there is high probability of contact between residues Phe 47/Phe 324 and Ile 48/Ile 325 of the AhR and the indole and tolylazo-phenyl groups of GNF-351 and CH223191, respectively. In the case of pyrene, the number of possible contacts between the ligand and the two residues are not significant (Fig. 4C) . Thus, the in silico modelling suggest that pyrene may act as a ligand for the AhR. However its docking into the AhR-PAS-B binding pocket differs from both "classical" agonists such as TCDD and B[a]P, as well as the two antagonists GNF-351 and CH223191.
Reciprocal antagonism between pyrene-induced [Ca
2+ ] i and B[a]Pinduced CYP1A1/CYP1B1
To further explore the nature of AhR-involvement in pyrene-induced [ (Fig. 5A) . In further agreement with our previous studies [16] , pyrene failed to induce CYP1A1/CYP1B1expression in HMEC-1 cells, while B[a]P induced a statistically significant increase (Fig. 5B) . Furthermore, co-exposure with pyrene attenuated B[a]P-induced CYP1A1/CYP1B1ex-pression (Fig. 5B) gradually levelled-off compared to the response in normal medium, and subsequently decreased from around 15 min (Fig. 7A ). This suggests that the initial phase of the response was due to Ca 2+ -release from intracellular stores, while later phase depended on influx of extracellular Ca 2+ . SKF 96365 had a similar effect; the initial response was intact, while the late response was partially inhibited (Fig. 8B) . SKF 96,365 is a store-operated Ca 2+ entry (SOCE) inhibitor that inhibits
Stromal interaction molecule 1 (STIM1), but also blocks transient and potassium channels. By comparison, 2APB seemed to inhibit both the initial and late response, probably due to its inhibiting effect on inositol trisphosphate-receptor (IP3R) as well as SOCE and TRP channels (Fig. 7C) . Surprisingly, BtP2, a potent blocker of SOCE and calcium release-activated calcium (CRAC) channels, abolished the Ca 2+ -response completely (Fig. 7D) . These result indicate that pyrene may 
Pyrene, but not B[a]P, reduced membrane lipid order in the plasma membrane through an AhR-dependent mechanism
It is known that Ca 2+ -influx can be affected by physico-chemical characteristics of membrane (eg. membrane order which reflect lipid packing depending on membrane fluidity and local lipid environment thus defining membrane microdomains), and PAHs like B[a]P have been shown to affect membrane fluidity [34, 35] . Moreover, alterations in ordered plasma membrane microdomains, such as caveolae, can affect calcium influx [36] . Thus we wanted to explore the possibility that pyrene affected the membrane microstructure in HMEC-1. Using the membrane order sensitive dye di-4-ANEPPDHQ, we observed that HMEC-1 cells exposed for 30 min to pyrene (1 µM) decreased global membrane lipid order compared to cells exposed to vehicle control (DMSO) (Fig. 8A and C) . By contrast, B[a]P did not affect membrane lipid order in the HMEC-1 cells as determined by di-4-ANEPPDHQ (Fig. 8A) . Furthermore, the pyrene-induced reduction in membrane order was reversed by pre-treatment with CH223191 ( Fig. 8B and C) . However, both pyrene and B[a]P, in a larger extent, induced an AhRdependent increase in bulk membrane fluidity measured by EPR (Fig. 9) . Thus, the pyrene-specific effect observed by di-4-ANEPPDHQ staining did not appear to be due to general alteration of membrane fluidity, but more likely restricted to effects on repartition between ordered and disordered membrane. In total, this indicates that pyrene may have induced an AhR-dependent destabilization of ordered plasma membrane microdomains in HMEC-1 cells. However, both pyrene and B
[a]P also seemed to elicit more general effects on membrane fluidity through AhR-dependent mechanisms.
Cholesterol, a plasma membrane ordering agent, attenuates pyreneinduced [Ca
2+ ] i increase
To explore if the membrane order-and the Ca 2+ -responses were linked, we pre-treated HMEC-1 with cholesterol for 30 min prior to pyrene exposure. The addition of cholesterol, which is known to increase membrane lipid order, partially inhibited the pyrene-induced [Ca 2+ ] i -response (Fig. 10) . Of interest, cholesterol treatment appeared to suppress both the initial and prolonged [Ca 2+ ] i -increase. Thus, it seems that cholesterol interacted with both the initial release from intracellular stores as well as the more secondary [Ca 2+ ] i -influx through the plasma membrane. This effect could possibly be related to cholesterol-induced changes in membrane lipid order although it should not be excluded that excess of cholesterol may also have influenced the rate of pyrene-diffusion through the cell membrane.
Discussion
Our present results show that pyrene acts as an antagonist with regard to AhR-genomic responses, but induced a relatively rapid AhRdependent increase in [Ca 2+ ] i within min after exposure, consistent with activation of AhR nongenomic signaling. In silico molecular modelling confirm that pyrene may dock in the human AhR-PAS-B binding pocket in the antagonist, but not the agonist conformation. The pyrene-induced [Ca 2+ ] i increase seemed to be initiated by Ca 2+ -release from intracellular stores followed by a later phase of extracellular Ca 2+ -influx. These effects appeared to be closely linked to an AhR-dependent disruption of lipid ordered membrane microdomains. The results show that pyrene induced cellular effects through molecular mechanisms distinctly different from B[a]P, and suggest that pyrene could act as a ] i was measured and normalized as described in Section 2. Measurements were started three min before exposure.
* Significantly different from pyrene-exposed HEK wt .
selective activator of AhR-nongenomic calcium signaling. Pyrene exposure did not trigger AhR-regulated gene expression when added alone, but reduced the B[a]P-induced CYP1A1/ CYP1B1expression by ∼50%, indicating that pyrene acts as an antagonist of the classical AhR-genomic signaling. In line with this, in silico molecular modelling indicated that pyrene preferentially docks into AhR-PAS-B binding pocket in the antagonist conformation. The previously proposed hypothesis regarding AhR function is that the 307-329 (αD-αF) segment of the human AhR behaves as a structural switch between an agonist to an antagonist conformation [30] . Based also on published AhR-HSP90 interaction studies, Bisson and colleagues [30] have suggested that AhR-antagonist binding results in a conformation change that either promotes premature dissociation of HSP90, or causes structural changes that inhibit AhR nuclear translocation. In particular, ligand interaction with residues Phe 47/Phe 324 and Ile 48/Ile 325 appear to play a critical role in the disruption of AhR-HSP90 interface [30] . Our present results suggest a high probability of contact between residues Phe 47/Phe 324 and Ile 48/Ile 325 of the AhR and the indole and tolylazo-phenyl groups of GNF-351 and CH223191, respectively. These antagonists are also capable of inhibiting nuclear translocation and/or AhR/Arnt heterodimerization, in vitro [37, 38] . In the case of pyrene, the number of possible contacts between the ligand and the two residues are not significant. The overall data suggest that pyrene is able to induce a conformational change of the AhR that differs from the one induced upon binding of either a full agonist (TCDD) or a full antagonist (GNF-351). Thus, AhR-nongenomic calcium signaling may not be restricted to classical agonists of the genomic pathway.
Exposing initiated by IP3R-mediated release of calcium from endoplasmic reticulum. Notably a high concentration of BTP2 (10 µM), a known SOCE-CRAC and TRPC channel inhibitor [41, 42] , abrogated the entire calcium response. It thus seems that a high dose of BTP2 affects calcium release from ER as well as SOCE-CRAC and TRPCs in our experimental system. Whether this observation could be due to off-target effects of the inhibitor remains unclear. Taken together our results indicate that pyrene triggers a rapid and substantial calcium release from intracellular stores, succeeded by an influx of calcium possibly through SOCE-CRAC and TRPC channels. 
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Changes in membrane microstructure may affect the activity of membrane bound proteins such as ion channels and receptors and may thus modify cell signaling events including calcium responses. Interestingly, pyrene induced an AhR-dependent disruption of lipid ordered membrane microdomains, as observed by use of di-4-ANEPP-DHQ-staining. It has recently been suggested that di-4-ANEPP-DHQ-staining which correlate with lipid order is less sensitive to membrane fluidity modifications than to cholesterol level changes in the membrane [43] . This could explain the lack of correlation with membrane fluidity measurements by EPR. Thus, the pyrene-induced AhR-dependent reduction in ΔGP could reflect a disruption in cholesterol-rich microdomains (reduction of their number or lowering their organisation). AhR has been reported to bind directly with caveolin-1 (Cav1) localized in caveolae, cholesterol rich microdomains and invaginations of the plasma membrane, and exposure to the AhR-ligand PCB77 further enhanced the AhR-Cav1 binding in vascular endothelial cells [44, 45] . AhR-expression also appears to regulate Cav1-localization in ordered microdomains, and that addition of cholesterol may switch the pattern of Cav1 localisation to a AhR−/− phenotype [45] . Caveolae function as Ca 2+ -signaling microdomains regulating SOCE channels, where Cav1 may act by coupling IP3R with TRPC-channels [36, 46] . It is therefore tempting to speculate that the pyrene-induced effects on Ca 2+ -signaling and ordered membrane microdomains is related to this association between AhR and Cav1 within the caveolae. In concordance with this, both Cav1 silencing and Ca 2+ -inhibition appear to attenuate AhR-induced CYP1A1 expression [44, 47] . Moreover, caveolins also appear to be central in directing the effects of nongenomic estrogen receptor and glucocorticoid receptor signaling by tethering the receptors into the caveolae and dictating the downstream cellular responses [5, 48] . Nongenomic signaling from a range of nuclear receptors may therefore share some common mechanisms. B[a]P has been shown to trigger an AhR-independent calcium response in HMEC-1 and HEK 293 cells mediated through activation of β2AR [26] . In contrast, the pyrene-induced [Ca 2+ ] i , was not only AhRdependent, but also partially suppressed by β1AR-overexpression and almost completely blocked by β2AR-overexpression in HEK293 cells. These results not only fortify the notion that B[a]P and pyrene elicit cellular effects through distinctly different mechanisms, but also suggest that β-adrenoceptors may affect AhR signaling. It has previously been reported that a PAH-mixture containing more than 50% pyrene impaired β2AR function in airway epithelial and smooth muscle cells [49] . A mutually suppressive crosstalk between AhR and β-adrenoceptor signaling may therefore exist. In light of this, it is interesting to note that also β-adrenoceptors appear to localize in caveolae and interact with caveolins [50, 51] . AhR nongenomic Ca 2+ -signaling has been proposed as a key mechanism regulating proinflammatory effects associated with TCDD poisoning (1). However, Ca 2+ is one of the main cellular second messengers and plays a central role in intracellular signal transduction and cell homeostasis as such [52, 53] ] i regulation in endothelial cells is pivotal to vascular signaling pathways, with important implications for regulating blood pressure and flow under physiological as well as pathophysiological conditions [53] . [Ca 2+ ] i is also involved in regulation of endothelial permeability [54] . Thus, disturbance of normal [Ca 2+ ] i in the vascular endothelium could be of importance to the cardiovascular effects associated with exposure to various AhR ligands [55] [56] [57] [58] .
Research on PCB-induced activation of nongenomic AhR-responses in the caveolae, have led to the suggestion that these cholesterol-rich microdomains could act as platforms for pro-inflammatory signaling and modulation of the pathology of vascular diseases [57] . In contrast to other AhR-agonists, pyrene alone appears to have limited impact on AhR-mediated gene expression. However, results from our laboratory show that pyrene may exacerbate pro-inflammatory responses induced by other agents [14] . The biological or toxicological implications of this apparent selective activation of AhR nongenomic calcium signaling therefore remains to clarify.
In conclusion, our present results show that pyrene act as an antagonist of the canonical genomic AhR/Arnt/CYP1-pathway, and a selective activator of AhR nongenomic signaling in endothelial cells, triggering a SOCE-mediated increase in [Ca 2+ ] i and alterations in plasma membrane microstructure. In silico molecular modelling confirms that pyrene may interact with the PAS-B binding pocket of the human AhR, but suggests that it may induce a conformational change that differs from those induced upon binding of either a full agonist or antagonist. These results support a notion that AhR genomic and nongenomic signaling could be triggered independently and that activation of AhR nongenomic signaling may not be restricted to the classical AhRagonists. ] i level measured by normalized ratio of the Fura-2-AM probe during exposure is presented as graph and the area under the curve (AUC) 0-30 min, as mean and mean ± SEM (n = 3), respectively. * Statistically significant effect of inhibitor.
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